LS&HC Horizons 2023 - Flipbook - Page 28
28
5
Transactions
UPC opt-out strategies for licensed European Patents:
be prepared by 1 March 2023
29
Non-dilutive funding opportunities for life sciences
and health care companies
30
Using CVRs to bridge valuation gaps in life sciences
M&A transactions
31
Companion diagnostics in collaborations
32
The rise of super-regional nonprofit health systems
33
Merger control and ‘killer acquisitions’
34
Implementation of master supply agreements:
a clash of theory and practice
35
